Latest news
Decentralised UACR-guided empagliflozin and finerenone therapy was feasible in T2D with CKD - Vera HealthVera Health · Wed, 05 Aug 2026 19:53:18 GMTAlternative complement pathway overactivation in IgA nephropathy - Vera HealthVera Health · Wed, 05 Aug 2026 19:42:40 GMTAdvanced CKD: low-dose rivaroxaban fails cardiovascular prevention and increases major bleeding - Vera HealthVera Health · Sun, 02 Aug 2026 05:53:15 GMTIgA nephropathy: iptacopan slows eGFR decline vs placebo - Vera HealthVera Health · Thu, 30 Jul 2026 20:24:35 GMT